Healthcare edtech startup Virohan has raised Rs 65 crore ($7.5 million) as part of its ongoing Series B funding round, led by Mynavi Corporation. The round also saw participation from Virohan’s existing investors including Blume Ventures, Bharat Inclusive Technologies Seed Fund, and Rebright Partners.
The funding will accelerate Virohan’s path to profitability through product innovation, operational efficiencies, and strategic talent expansion, the company said in a press release.
Entrackr exclusively reported about the deal earlier this month.
Virohan works with universities such as UPES, BBD University, CMR University, Assam Don Bosco University, and G.H. Raisoni University to offer undergraduate programs in allied healthcare, nursing, and healthcare management, and partners with healthcare companies including Lenskart, Medanta, Healthians, and Dr. Lal PathLabs to support student placements.
The seven-year-old firm claims to have partnered with more than 20 higher education institutions, trained over 13,000 healthcare students, and worked with over 2,000 healthcare employers to support graduate employability.
Virohan has raised over $25 million in funding so far. According to TheKredible, after the latest share allotment, Mynavi Corporation will hold a 3.83% stake in the company, while Blume Ventures will continue as the largest shareholder with a 16.16% holding.
The company is yet to file its FY25 financials. In FY24, Virohan reported operating revenue of Rs 21 crore, up from Rs 10.65 crore in FY23, while its losses widened 18% year on year to Rs 22 crore.
